Natus Medical plunges on missed Q2 sales

July 8, 2013 by Sony Salzman

Natus Medical's preliminary sales results for the 2nd quarter miss its own forecast, sending share prices down more than 12% today on Wall Street.

Natus Medical plunges on missed Q2 sales

Natus Medical (NSDQ:BABY) took a hit after the company announced missed 2nd-quarter sales, sending prices down more than 12% on Wall Street.

The San Carlos, Calif.-based company said it expects to post sales of $81 million to $82 million for the 3 months ended June 30, down 5.8%-8.9% from its prior guidance of $86 million to $90 million.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp